Home Sulfos Methanesulfonamide

Methanesulfonamide

CAS No.:
3144-09-0
Catalog Number:
AG00354U
Molecular Formula:
CH5NO2S
Molecular Weight:
95.1209
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
10g
95%
In Stock USA
United States
$12
- +
25g
95%
In Stock USA
United States
$18
- +
100g
98%
In Stock USA
United States
$50
- +
500g
98%
In Stock USA
United States
$188
- +
Product Description
Catalog Number:
AG00354U
Chemical Name:
Methanesulfonamide
CAS Number:
3144-09-0
Molecular Formula:
CH5NO2S
Molecular Weight:
95.1209
MDL Number:
MFCD00007940
IUPAC Name:
methanesulfonamide
InChI:
InChI=1S/CH5NO2S/c1-5(2,3)4/h1H3,(H2,2,3,4)
InChI Key:
HNQIVZYLYMDVSB-UHFFFAOYSA-N
SMILES:
CS(=O)(=O)N
EC Number:
221-553-6
NSC Number:
271
Properties
Complexity:
95.3  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
95.004g/mol
Formal Charge:
0
Heavy Atom Count:
5  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
95.116g/mol
Monoisotopic Mass:
95.004g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
68.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.1  
Literature
Title Journal
A novel carbohydrate derived compound FCP5 causes DNA strand breaks and oxidative modifications of DNA bases in cancer cells. Chemico-biological interactions 20150205
Pyrrolo[2,3-b]quinoxalines as inhibitors of firefly luciferase: their Cu-mediated synthesis and evaluation as false positives in a reporter gene assay. Bioorganic & medicinal chemistry letters 20121015
Amide derivatives of benzene-sulfonanilide, pharmaceutical composition thereof and method for cancer treatment using the same (US20120095092). Expert opinion on therapeutic patents 20121001
RCAI-84, 91, and 105-108, ureido and thioureido analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines. Bioorganic & medicinal chemistry 20120715
Conformational analysis, vibrational and NMR spectroscopic study of the methanesulfonamide-N,N'-1,2-ethanediylbis. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120601
Total synthesis of a marine alkaloid--rigidin E. Marine drugs 20120601
Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamido acetophenone derivatives as non ulcerogenic anti-inflammatory agents. European journal of medicinal chemistry 20120301
Rosuvastatin blocks hERG current and prolongs cardiac repolarization. Journal of pharmaceutical sciences 20120201
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone. Clinical interventions in aging 20120101
Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease. Clinical Medicine Insights. Cardiology 20120101
N-[4-(4-Fluoro-phen-yl)-5-hy-droxy-methyl-6-isopropyl-pyrimidin-2-yl]-N-methyl-methane-sulfonamide. Acta crystallographica. Section E, Structure reports online 20111201
The structure of NS-398 bound to cyclooxygenase-2. Journal of structural biology 20111101
Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors. Bioorganic & medicinal chemistry letters 20110701
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs. Journal of medicinal chemistry 20110609
Discovery of new chromone containing sulfonamides as potent inhibitors of bovine cytosolic carbonic anhydrase. Bioorganic & medicinal chemistry 20110601
N,N'-Dibenzyl-N,N'-dimethyl-N''-(methyl-sulfon-yl)phospho-ric triamide. Acta crystallographica. Section E, Structure reports online 20110601
Mild Pd-catalyzed N-arylation of methanesulfonamide and related nucleophiles: avoiding potentially genotoxic reagents and byproducts. Organic letters 20110520
2-(N-Phenyl-methane-sulfonamido)-ethyl 1H-pyrrole-2-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20110501
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly. Clinical interventions in aging 20110101
Application of molecular topology for the prediction of reaction yields and anti-inflammatory activity of heterocyclic amidine derivatives. International journal of molecular sciences 20110101
Optimization of Benzoisothiazole dioxide inhibitory activity of the NS5B polymerase of HCV genotype 4 using ligand-steered homological modeling, reaction-driven scaffold-hopping and Enovo workflow. Bioinformation 20110101
A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity. Journal of medicinal chemistry 20101111
Expanding the diversity of allosteric bcr-abl inhibitors. Journal of medicinal chemistry 20101014
Impact of dronedarone in atrial fibrillation and flutter on stroke reduction. Clinical interventions in aging 20100101
Studies of benzothiadiazine derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics. Current medicinal chemistry 20100101
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides. Bioorganic & medicinal chemistry letters 20091001
Bis(tetra-phenyl-phospho-nium) tris-[N-(methyl-sulfon-yl)dithio-carbimato(2-)-κS,S']stannate(IV). Acta crystallographica. Section E, Structure reports online 20091001
Synthesis, antiviral and anticancer activity of some novel thioureas derived from N-(4-nitro-2-phenoxyphenyl)-methanesulfonamide. European journal of medicinal chemistry 20090901
Novel indoline-based acyl-CoA: cholesterol acyltransferase inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities. Bioorganic & medicinal chemistry 20090815
Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer. British journal of cancer 20090804
Synthesis, anticancer, and anti-inflammatory activity evaluation of methanesulfonamide and amidine derivatives of 3,4-diaryl-2-imino-4-thiazolines. Molecular diversity 20090801
Development and validation of an LC-MS/MS method for determination of methanesulfonamide in human urine. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090715
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinediones. Bioorganic & medicinal chemistry letters 20090701
Methanesulfonamide: a cosolvent and a general acid catalyst in sharpless asymmetric dihydroxylations. The Journal of organic chemistry 20090417
Cytotoxic activity of platinum(II) and palladium(II) complexes of N-3-pyridinylmethanesulfonamide: the influence of electroporation. Zeitschrift fur Naturforschung. C, Journal of biosciences 20090101
Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis. PloS one 20090101
Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemics. Drug, healthcare and patient safety 20090101
An experimental and theoretical study of dipole moments of N-[4-(9-acridinylamino)-3-methoxyphenyl]methanesulfonamide. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080901
(4R)-4-[(1R)-1,2-Dihydroxy-ethyl]-1-[(1R)-1-phenyl-ethyl]pyrrolidin-2-one. Acta crystallographica. Section E, Structure reports online 20080901
Clinical efficacy and safety of statins in managing cardiovascular risk. Vascular health and risk management 20080401
beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification. Bioorganic & medicinal chemistry letters 20080201
Methyl 2-(N-ethyl-methane-sulfonamido)benzoate. Acta crystallographica. Section E, Structure reports online 20080201
Synthesis and biological evaluation of novel sulfonanilide compounds as antiproliferative agents for breast cancer. Journal of combinatorial chemistry 20080101
A new strategy for the synthesis of benzylic sulfonamides: palladium-catalyzed arylation and sulfonamide metathesis. The Journal of organic chemistry 20071012
Discovery of a highly active ligand of human pregnane x receptor: a case study from pharmacophore modeling and virtual screening to 'in vivo' biological activity. Molecular pharmacology 20070901
Optimization of triaryl bis-sulfones as cannabinoid-2 receptor ligands. Bioorganic & medicinal chemistry letters 20070701
A single component ratiometric pH probe with long wavelength excitation of europium emission. Chemical communications (Cambridge, England) 20070207
Synthesis and biological evaluation of methanesulfonamide analogues of rofecoxib: Replacement of methanesulfonyl by methanesulfonamido decreases cyclooxygenase-2 selectivity. Bioorganic & medicinal chemistry 20070115
Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents. Current drug metabolism 20061001
Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorganic & medicinal chemistry letters 20051201
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors. Bioorganic & medicinal chemistry letters 20050502
Structural determinants of HERG channel block by clofilium and ibutilide. Molecular pharmacology 20040801
[Synthesis and anti-inflammatory activity of N-(4-arylamidophenyl) methanesulfonamide derivatives]. Yao xue xue bao = Acta pharmaceutica Sinica 20040701
Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors. Bioorganic & medicinal chemistry letters 20040405
N-4-Substituted-benzyl-N'-tert-butylbenzyl thioureas as vanilloid receptor ligands: investigation on the role of methanesulfonamido group in antagonistic activity. Bioorganic & medicinal chemistry letters 20040209
Differential recovery of action potential duration and HERG currents from the effects of two methanesulfonamide class III antiarrhythmic agents, KCB-328 and dofetilide. Journal of cardiovascular pharmacology 20031101
Variations of acidic functions at position 2 and substituents at positions 4, 5 and 6 of the indole moiety and their effect on NMDA-glycine site affinity. European journal of medicinal chemistry 20031001
Synthesis and prostaglandin synthase inhibitory activity of new aromatic O-alkyloxime ethers substituted with methylsulfonamido or methylsulfonyl groups on their aliphatic portion. Farmaco (Societa chimica italiana : 1989) 20030901
Acetic acid-derived prostaglandin-dependent colonic adaptive cytoprotection is preserved in chronic colitis: role of cyclo-oxygenase. International journal of colorectal disease 20030501
[Anti-arrhythmic action of N-(aminoalkylene) derivatives of indoline-2,3-diones and 1,2-benzene-dicarboxiamides]. Medicina (Kaunas, Lithuania) 20020101
Substituted indole-5-carboxamides and -acetamides as potent nonpeptide GnRH receptor antagonists. Bioorganic & medicinal chemistry letters 20010709
Properties